News & Updates

Among patients with hidradenitis suppurativa, treatment satisfaction is high for those who are treated by a dermatologist and receive a biologic medication, a study has found.

A phase IIb trial has found that TMB-001, a novel topical isotretinoin ointment, can safely improve symptoms of hyperkeratosis and widespread scaling in patients with X-linked recessive or autosomal recessive congenital ichthyosis (CI).

Photodynamic therapy using topically applied hypericin 0.25% is effective against early-stage patch and plaque lesions in patients with mycosis fungoides−cutaneous T-cell lymphoma, while having a favourable safety profile, as shown in the phase III FLASH trial.

A weekly treatment schedule of hypofractionated radiotherapy appears to yield good response rate in elderly patients with cutaneous squamous cell carcinoma (cSCC), while having minimal side effects, a study has shown.

Having an atopic eczema appears to slightly increase one’s risk of incident dementia, particularly among older adults, suggests a study. Such risk further grows with the severity of atopic eczema.

A recent study has identified three different clusters of bullous pemphigoid (BP), which includes one corresponding to severe BP180+ BP230− with features common to mucous membrane pemphigoid.

Very few patients with cutaneous lupus erythematosus (CLE) achieve long-term remission, which is negatively associated with active smoking and discoid CLE, reports a study.